MX2016016885A - Administracion in ovo de cultivos probioticos. - Google Patents
Administracion in ovo de cultivos probioticos.Info
- Publication number
- MX2016016885A MX2016016885A MX2016016885A MX2016016885A MX2016016885A MX 2016016885 A MX2016016885 A MX 2016016885A MX 2016016885 A MX2016016885 A MX 2016016885A MX 2016016885 A MX2016016885 A MX 2016016885A MX 2016016885 A MX2016016885 A MX 2016016885A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine
- strain
- probiotic
- crops
- ovo administration
- Prior art date
Links
- 239000006041 probiotic Substances 0.000 title abstract 3
- 230000000529 probiotic effect Effects 0.000 title abstract 3
- 235000018291 probiotics Nutrition 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 abstract 4
- 241000271566 Aves Species 0.000 abstract 3
- 238000002255 vaccination Methods 0.000 abstract 3
- 241000894006 Bacteria Species 0.000 abstract 2
- 244000144977 poultry Species 0.000 abstract 2
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K45/00—Other aviculture appliances, e.g. devices for determining whether a bird is about to lay
- A01K45/007—Injecting or otherwise treating hatching eggs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
- A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
- C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Mycology (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Food Science & Technology (AREA)
- Birds (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Environmental Sciences (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Biodiversity & Conservation Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
La presente invención se refiere generalmente a una cepa de bacteria probiótica Latobacillus y una vacuna aviaria para uso en la vacunación in ovo de las aves, en donde dicha cepa y dicha vacuna se administran a un huevo embrionado de aves de corral. Asimismo se proporcionan composiciones adecuadas para uso en un protocolo de vacunación in ovo para aves de corral comprende una cepa de bacteria probiótica Lactobacillus y un diluyente de vacuna que es adecuado para vacuna aviaria para utilizarse en dicho protocolo de vacunación, así como estuches adecuados para el uso en la invención.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462016285P | 2014-06-24 | 2014-06-24 | |
| PCT/EP2015/064310 WO2015197728A1 (en) | 2014-06-24 | 2015-06-24 | In ovo delivery of probiotic cultures |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2016016885A true MX2016016885A (es) | 2017-04-27 |
| MX387170B MX387170B (es) | 2025-03-18 |
Family
ID=53498985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016016885A MX387170B (es) | 2014-06-24 | 2015-06-24 | Administración in ovo de cultivos probióticos. |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US10143713B2 (es) |
| EP (1) | EP3160224B1 (es) |
| BR (1) | BR112016030294A8 (es) |
| DK (1) | DK3160224T3 (es) |
| ES (1) | ES2829824T3 (es) |
| MX (1) | MX387170B (es) |
| WO (1) | WO2015197728A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3481181A4 (en) * | 2016-07-11 | 2020-03-04 | The Board of Trustees of The University of Arkansas | PROBIOTIC VACCINE COMPOSITIONS FOR POULTRY AND METHODS OF USE THEREOF |
| US20180153945A1 (en) * | 2016-12-05 | 2018-06-07 | The United States Of America, As Represented By The Secretary Of Agriculture | Oral e. coli vector-based vaccine for prevention of coccidiosis in poultry |
| EP3735134A4 (en) * | 2018-01-04 | 2022-01-19 | White Dog Labs, Inc. | METHOD AND COMPOSITION FOR IMPROVING ANIMAL HEALTH COMPRISING ORGANIC CELLS CONSISTING OF STEM IN THE ORDER CLOSTRIDIALES |
| EP4040984A4 (en) * | 2019-09-25 | 2024-01-17 | Tall Goods, LLC | METHOD FOR PRODUCING PROBIOTICALLY ENHANCED BIRD EGGS AND EGG PRODUCTS AND FORMULATIONS THEREOF |
| IT202100016055A1 (it) * | 2021-06-18 | 2022-12-18 | Univ Degli Studi Di Camerino | Composizione comprendente estratto secco di contenuto intestinale di polli adulti liofilizzato, relativo uso come integratore alimentare e relativo uso per stimolare il sistema immunitario |
| US20230082935A1 (en) * | 2021-09-16 | 2023-03-16 | Nutritional Health Institute Laboratories, Llc | In ovo vaccines in combination with probiotics |
| CN117757892B (zh) * | 2024-02-22 | 2024-06-11 | 潍坊华卓生物科技有限公司 | 预防鸡新城疫病毒的功能性益生菌反向筛选方法及应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX9200354A (es) * | 1991-01-28 | 1993-08-01 | Biogaia Biolog Ab | Metodo para administrar microorganismos directos de alimentacion a aves, en el huevo |
| US5534253A (en) * | 1995-06-07 | 1996-07-09 | Biogaia Ab | Method of treating enteropathogenic bacterial infections in poultry |
| RU2409385C2 (ru) | 2006-03-30 | 2011-01-20 | Эмбрекс, Инк. | Способ иммунизации птицы против инфекции, вызванной бактериями clostridium |
-
2015
- 2015-06-24 EP EP15733403.8A patent/EP3160224B1/en not_active Not-in-force
- 2015-06-24 BR BR112016030294A patent/BR112016030294A8/pt not_active Application Discontinuation
- 2015-06-24 WO PCT/EP2015/064310 patent/WO2015197728A1/en not_active Ceased
- 2015-06-24 DK DK15733403.8T patent/DK3160224T3/da active
- 2015-06-24 MX MX2016016885A patent/MX387170B/es unknown
- 2015-06-24 ES ES15733403T patent/ES2829824T3/es active Active
- 2015-06-24 US US15/108,047 patent/US10143713B2/en active Active
-
2017
- 2017-11-27 US US15/823,136 patent/US10143714B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10143713B2 (en) | 2018-12-04 |
| MX387170B (es) | 2025-03-18 |
| US20180078590A1 (en) | 2018-03-22 |
| ES2829824T3 (es) | 2021-06-02 |
| EP3160224B1 (en) | 2020-08-05 |
| DK3160224T3 (da) | 2020-11-09 |
| BR112016030294A8 (pt) | 2021-04-13 |
| WO2015197728A1 (en) | 2015-12-30 |
| EP3160224A1 (en) | 2017-05-03 |
| BR112016030294A2 (pt) | 2017-08-22 |
| US10143714B2 (en) | 2018-12-04 |
| US20170095516A1 (en) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016016885A (es) | Administracion in ovo de cultivos probioticos. | |
| CL2018001056A1 (es) | Vacuna contra el virus herpes simplex | |
| CL2018001053A1 (es) | Vacuna contra el virus sincicial respiratorio | |
| BR112017001310A2 (pt) | coronavírus | |
| MX2016010651A (es) | Vacunas de virus aviar que son estables en liquido. | |
| BR112017003462A2 (pt) | coronavírus bovino atenuado, vacina, e, método de vacinação de um bovino. | |
| MX2016006189A (es) | Extracto de algas para su uso en calidad de agente inmunomodulador. | |
| CO2018005971A2 (es) | Composición de regulador de crecimiento vegetal que tiene efecto sinérgico | |
| MX2017000775A (es) | Vacunas de meningococos. | |
| BR112016023613A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| MX2018016306A (es) | Virus de enteritis de pato y usos del mismo. | |
| BR112015025748A2 (pt) | construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna | |
| MX2018012285A (es) | Metodos de tratamiento para enfermedades colestasicas y fibroticas. | |
| BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| MX381252B (es) | Virus de la enteritis del pato y usos del mismo. | |
| AR103531A1 (es) | Composiciones de caldo y su uso como prebióticos | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| UY36405A (es) | Formulaciones reguladoras/bioestimulantes del crecimiento de las plantas y de los cultivos y métodos para usarlas | |
| MX2016013277A (es) | Vacuna para estreptococo de grupo a. | |
| PH12020500342A1 (en) | New disinfectant for hatcheries | |
| EA201991319A1 (ru) | Вакцины аттенуированного свиного гриппа и способы их изготовления и применения | |
| CL2017001454A1 (es) | Métodos para preparar composiciones que contienen alcaloides y usos de las mismas | |
| CL2016001906A1 (es) | Vacunas contra el reovirus aviar. | |
| BR112017006620A2 (pt) | vacina, métodos para a preparação de uma vacina e para reduzir infecção por reovírus aviário, composição, e, usos de material antigênico e de uma vacina. | |
| MX2017009796A (es) | Mdv1 recombinantes y usos de los mismos. |